Richard Macaluso (30 results)

Condition: good. The book is in good condition with all pages and cover intact, including the dust jacket if originally issued. The spine may show light wear. Pages may contain some notes or highlighting, and there might be a "From the library of" label. Boxed set packaging, shrink wrap, or included media like CDs may be missing.

PAPERBACK. Condition: VERY GOOD. AN EXTREMELY CLEAN AND BRIGHT UNMARKED COPY OF THIS BOOK.

Condition: good. Good condition. A copy that has been read but remains in clean condition. All pages are intact and the cover is intact. The spine and cover may show signs of wear. Pages can include limited notes and highlighting, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation. If you're not satisfied with purchase please just return it!

Condition: New.

Condition: New. pp. 274.

Condition: New. pp. 274.

Soft cover. Stated first edition. Illustrated in black, white and color. Important reference work. Very scarce in this condition. Signed by the author. Fine copy. 168 pps.

Condition: New. In.

Condition: New. In.

Condition: New.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:a. Prior to the 1960s - Drug discovery by chance observationb. The last 50 years - refined targeting of CNS drugs without the discovery of mechanistically new drugsc. The future - the discovery and development of mechanistically new drugs. The examination of new targets, genetics and biomarkers.

Condition: New. 2023rd edition NO-PA16APR2015-KAP.

Condition: New. 2023rd edition NO-PA16APR2015-KAP.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:a. Prior to the 1960s - Drug discovery by chance observationb. The last 50 years - refined targeting of CNS drugs without the discovery of mechanistically new drugsc. The future - the discovery and development of mechanistically new drugs. The examination of new targets, genetics and biomarkers.

Hardcover. Condition: Brand New. 467 pages. 9.25x6.10x1.26 inches. In Stock.

Condition: New.

PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Condition: new. Questo è un articolo print on demand.

Condition: new. Questo è un articolo print on demand.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:a. Prior to the 1960s - Drug discovery by chance observationb. The last 50 years - refined targeting of CNS drugs without the discovery of mechanistically new drugsc. The future - the discovery and development of mechanistically new drugs. The examination of new targets, genetics and biomarkers. 468 pp. Englisch.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The rea.

Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The rea.

Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:a. Prior to the 1960s - Drug discovery by chance observationb. The last 50 years - refined targeting of CNS drugs without the discovery of mechanistically new drugsc. The future - the discovery and development of mechanistically new drugs. The examination of new targets, genetics and biomarkers. 468 pp. Englisch.

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:a. Prior to the 1960s - Drug discovery by chance observationb. The last 50 years - refined targeting of CNS drugs without the discovery of mechanistically new drugsc. The future - the discovery and development of mechanistically new drugs. The examination of new targets, genetics and biomarkers.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 468 pp. Englisch.

Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:a. Prior to the 1960s - Drug discovery by chance observationb. The last 50 years - refined targeting of CNS drugs without the discovery of mechanistically new drugsc. The future - the discovery and development of mechanistically new drugs. The examination of new targets, genetics and biomarkers.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 468 pp. Englisch.

Condition: New. Print on Demand.

Condition: New. Print on Demand.

Condition: New. PRINT ON DEMAND.

Condition: New. PRINT ON DEMAND.